LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    EuropaBio recommendations for the Bioeconomy Strategy

    24/06/2025

    The Bioeconomy strategy is an important step to preserve Europe’s competitiveness and to support the EU’s industrial decarbonisation and growth through innovation. It can drive forward the transition away from a petroleum-based society and should therefore be considered a core pillar of the EU’s industrial policy. It should build upon previous strategies and foster EU policy coherence, predictability and alignment with all other relevant announced initiatives, including the EU Biotech Act, the Life Science Strategy and the Clean Industrial Deal.

    EuropaBio is a member of the European Bioeconomy Alliance (EUBA) which represents sectors that bring together 29 million professionals who produce, use, refine and transform bio-based renewable feedstock into food, feed, chemicals, manufacturing materials, biofuels, and bioenergy. We support EUBA’s position calling on the bioeconomy strategy to build a reliable policy framework in which the bioeconomy can attract capital, contribute to sustainable growth and fulfil its immense potential.

    Biotechnologies play an essential role for the delivery of EU goals for competitive, healthy, resilient and sustainable economies and societies. Biotech is a driver of high value and disruptive innovation. It is also unique as it enables the production of biologically active and structurally complex molecules that conventional chemistry cannot generally manufacture or produce efficiently. This makes biotechnology applications indispensable in health, agri-food, chemicals, manufacturing of consumer goods and more throughout our industrial and social ecosystems. It is a hallmark of success, demonstrating EU growth and benefit through innovation. The EU must therefore urgently prioritise their scale-up and access to EU and global markets, as this will be vital for the EU to stay in the global race of clean and disruptive technologies.

    As a first step, the Bioeconomy Strategy must set the right direction by acting in the following policy areas:

    1. Security of investment
    2. Market access
    3. Innovation and skills

     

    Read and download the full recommendations below

    EuropaBio recommendations for the Bioeconomy Strategy


    Download
    Share
    Adrian Lincoln
    Adrian Lincoln

    Related posts

    06/03/2026

    Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe


    Read more
    13/02/2026

    The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies


    Read more
    11/02/2026

    Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026


    Read more

    Important links

    • Bene Meat Technologies joins EuropaBio: Advancing Cultivated Meat in Europe
    • The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.